{"id":"placebo-like-amitriptyline","safety":{"commonSideEffects":[]},"_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=placebo like amitriptyline","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T05:28:04.063645+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T05:28:09.109232+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=placebo like amitriptyline","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T05:28:09.465358+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Norepinephrine transporter inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:28:10.590422+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200964/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:28:10.244857+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a placebo comparator, this drug contains no active pharmaceutical ingredient but is formulated to resemble amitriptyline in appearance and administration. It is used in clinical trials to control for placebo effects when evaluating amitriptyline's therapeutic efficacy. The reference drug amitriptyline works by inhibiting the reuptake of norepinephrine and serotonin at neuronal synapses, thereby increasing their synaptic concentrations.","oneSentence":"This is a placebo formulation designed to mimic amitriptyline, a tricyclic antidepressant that blocks reuptake of norepinephrine and serotonin.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:01:09.017Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:28:11.960609+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Clinical trial control for depression, anxiety, or chronic pain conditions (as comparator to amitriptyline)"}]},"trialDetails":[{"nctId":"NCT01206478","phase":"PHASE2","title":"Trial of Amitriptyline for Chronic Oral Food Refusal in Children 9 Months to 8 Years of Age","status":"COMPLETED","sponsor":"Ann Davis, PhD, MPH, ABPP","startDate":"2010-08","conditions":"Chronic Oral Food Refusal","enrollment":21},{"nctId":"NCT02190526","phase":"PHASE4","title":"Effects of Mesalamine and Amitriptyline on Irritable Bowel Syndrome","status":"WITHDRAWN","sponsor":"Tehran University of Medical Sciences","startDate":"2014-09","conditions":"Diarrhea- Predominant Irritable Bowel Syndrome, Quality of Life","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL1200964"},"_approvalHistory":[],"publicationCount":24,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"placebo like amitriptyline","genericName":"placebo like amitriptyline","companyName":"Tehran University of Medical Sciences","companyId":"tehran-university-of-medical-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Amitriptyline, a serotonin transporter inhibitor, has been studied in clinical trials for various conditions, including Diarrhea-Predominant Irritable Bowel Syndrome, Quality of Life, Chronic Oral Food Refusal, and Quiescent Crohn's Disease. In these trials, amitriptyline was compared to a placebo-like intervention, such as a placebo-like version of the medication Mesalazine.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:28:11.960609+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}